Jeito
Claudio Costa-Neto has a vast experience in the field of biochemistry and molecular pharmacology. Currently serving as the Chief Scientific Officer and Operational Investor at Jeito Capital, Claudio is also a Professor at Faculdade de Medicina de Ribeirão Preto / USP. With previous roles at InterAx Biotech AG, Sofinnova Partners, Collège de France, and University of Copenhagen, Claudio has a strong background in academia and venture consulting. Their educational background includes a PhD in Molecular Biology from Unifesp and Københavns Universitet, as well as a BS in Biology from UFSCar.
Jeito
Jeito is a next-generation fund with a patient benefit driven approach, that focuses both on financing ground-breaking medical innovation and promoting positive societal impact.